Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 5374897, 12 pages
https://doi.org/10.1155/2017/5374897
Research Article

Sulforaphane Prevents Angiotensin II-Induced Testicular Cell Death via Activation of NRF2

1Department of Urology, China-Japan Union Hospital of Jilin University, 126 Xiantai St, Changchun, Jilin 130033, China
2Pediatric Research Institute, Department of Pediatrics, Wendy L. Novak Diabetes Care Center, University of Louisville, 570 S Preston St, Louisville, KY 40202, USA
3Department of Nephrology, The Second Hospital of Jilin University, 218 Ziqiang St, Changchun, Jilin 130041, China
4The Key Laboratory of Pathobiology, Ministry of Education, The Norman Bethune Medical College, Jilin University, Changchun, Jilin 130021, China
5Cardiovascular Center, The First Hospital of Jilin University, 71 Xinmin St, Changchun, Jilin 130021, China
6Department of Nephrology, The First Hospital of Jilin University, 71 Xinmin St, Changchun, Jilin 130021, China
7Chinese-American Research Institute for Diabetic Complications, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, Zhejiang, China
8Department of Nephrology, China-Japan Union Hospital of Jilin University, Changchun, China, 126 Xiantai St, Changchun, Jilin 130033, China

Correspondence should be addressed to Hao Wu; nc.ude.ulj@ahaboahuw, Feng Liu; moc.361@gnefuildj, and Lu Cai; ude.ellivsiuol@100iac0l

Received 31 July 2016; Revised 28 November 2016; Accepted 12 December 2016; Published 16 January 2017

Academic Editor: Christian Wigley

Copyright © 2017 Yonggang Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Chehab, A. Madala, and J. C. Trussell, “On-label and off-label drugs used in the treatment of male infertility,” Fertility and Sterility, vol. 103, no. 3, pp. 595–604, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. A. B. Atkinson, J. J. Brown, R. Fraser et al., “Angiotensin II and renal hypertension in dog, rat and man: effect of converting enzyme inhibition,” Clinical and Experimental Hypertension, vol. 2, no. 3-4, pp. 499–524, 1980. View at Publisher · View at Google Scholar · View at Scopus
  3. J. T. Fitzsimons, “Angiotensin II in the control of hypovolaemic thirst and sodium appetite,” Canadian Journal of Physiology and Pharmacology, vol. 58, no. 5, pp. 441–444, 1980. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Kono, F. Ikeda, F. Oseko, H. Imura, S. Shimbo, and J. Endo, “Angiotensin II analogue and essential hypertension,” Nippon Rinsho, vol. 37, no. 10, pp. 3503–3510, 1979. View at Google Scholar · View at Scopus
  5. M. Gianzo, I. Muñoa-Hoyos, I. Urizar-Arenaza et al., “Angiotensin II type 2 receptor is expressed in human sperm cells and is involved in sperm motility,” Fertility and Sterility, vol. 105, no. 3, pp. 608–616, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Rossi, A. Ferraresi, P. Romagni, L. Silvestroni, and V. Santiemma, “Angiotensin II stimulates contraction and growth of testicular peritubular myoid cells in vitro,” Endocrinology, vol. 143, no. 8, pp. 3096–3104, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Welter, A. Huber, S. Lauf et al., “Angiotensin II regulates testicular peritubular cell function via AT1 receptor: a specific situation in male infertility,” Molecular and Cellular Endocrinology, vol. 393, no. 1-2, pp. 171–178, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. S. I. Dikalov, R. R. Nazarewicz, A. Bikineyeva et al., “Nox2-induced production of mitochondrial superoxide in angiotensin II-mediated endothelial oxidative stress and hypertension,” Antioxidants and Redox Signaling, vol. 20, no. 2, pp. 281–294, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Kossmann, H. Hu, S. Steven et al., “Inflammatory monocytes determine endothelial nitric-oxide synthase uncoupling and nitro-oxidative stress induced by Angiotensin II,” Journal of Biological Chemistry, vol. 289, no. 40, pp. 27540–27550, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Tan, X. Li, S. D. Prabhu et al., “Angiotensin II plays a critical role in alcohol-induced cardiac nitrative damage, cell death, remodeling, and cardiomyopathy in a protein kinase c/nicotinamide adenine dinucleotide phosphate oxidase-dependent manner,” Journal of the American College of Cardiology, vol. 59, no. 16, pp. 1477–1486, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Yang, Y. Tan, F. Zhao et al., “Angiotensin II plays a critical role in diabetic pulmonary fibrosis most likely via activation of NADPH oxidase-mediated nitrosative damage,” American Journal of Physiology—Endocrinology and Metabolism, vol. 301, no. 1, pp. E132–E144, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Kaushal and M. P. Bansal, “Selenium variation induced oxidative stress regulates p53 dependent germ cell apoptosis: plausible involvement of HSP70-2,” European Journal of Nutrition, vol. 48, no. 4, pp. 221–227, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Muratori, L. Tamburrino, S. Marchiani et al., “Investigation on the origin of sperm DNA fragmentation: role of apoptosis, immaturity and oxidative stress,” Molecular Medicine, vol. 21, pp. 109–122, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Shiraishi, H. Takihara, and H. Matsuyama, “Elevated scrotal temperature, but not varicocele grade, reflects testicular oxidative stress-mediated apoptosis,” World Journal of Urology, vol. 28, no. 3, pp. 359–364, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Song, Y. Shi, H. Yu, Y. Hu, Y. Wang, and K. Yang, “P,p′-Dichlorodiphenoxydichloroethylene induced apoptosis of Sertoli cells through oxidative stress-mediated p38 MAPK and mitochondrial pathway,” Toxicology Letters, vol. 202, no. 1, pp. 55–60, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. Y.-C. Yeh, T.-J. Liu, L.-C. Wang et al., “A standardized extract of Ginkgo biloba suppresses doxorubicin-induced oxidative stress and p53-mediated mitochondrial apoptosis in rat testes,” British Journal of Pharmacology, vol. 156, no. 1, pp. 48–61, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Chhunchha, N. Fatma, E. Kubo, P. Rai, S. P. Singh, and D. P. Singh, “Curcumin abates hypoxia-induced oxidative stress based-ER stress-mediated cell death in mouse hippocampal cells (HT22) by controlling Prdx6 and NF-κB regulation,” American Journal of Physiology—Cell Physiology, vol. 304, no. 7, pp. C636–C655, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. C. W. Younce and P. E. Kolattukudy, “MCP-1 causes cardiomyoblast death via autophagy resulting from ER stress caused by oxidative stress generated by inducing a novel zinc-finger protein, MCPIP,” Biochemical Journal, vol. 426, no. 1, pp. 43–53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Gong, J. Wu, Y. Huang, S. Shen, and X. Han, “Nonylphenol induces apoptosis in rat testicular Sertoli cells via endoplasmic reticulum stress,” Toxicology Letters, vol. 186, no. 2, pp. 84–95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. Y.-L. Ji, H. Wang, C. Zhang et al., “N-acetylcysteine protects against cadmium-induced germ cell apoptosis by inhibiting endoplasmic reticulum stress in testes,” Asian Journal of Andrology, vol. 15, no. 2, pp. 290–296, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. Y.-L. Ji, H. Wang, X.-F. Zhao et al., “Crosstalk between endoplasmic reticulum stress and mitochondrial pathway mediates cadmium-induced germ cell apoptosis in testes,” Toxicological Sciences, vol. 124, no. 2, pp. 446–459, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Lin, F. Chen, J. Sun et al., “Mycotoxin zearalenone induces apoptosis in mouse Leydig cells via an endoplasmic reticulum stress-dependent signalling pathway,” Reproductive Toxicology, vol. 52, pp. 71–77, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. S.-J. Park, T.-S. Kim, C.-K. Park et al., “hCG-induced endoplasmic reticulum stress triggers apoptosis and reduces steroidogenic enzyme expression through activating transcription factor 6 in Leydig cells of the testis,” Journal of Molecular Endocrinology, vol. 50, no. 2, pp. 151–166, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Dandekar, R. Mendez, and K. Zhang, “Cross talk between ER stress, oxidative stress, and inflammation in health and disease,” Methods in Molecular Biology, vol. 1292, pp. 205–214, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Kaneto, “Oxidative stress and ER stress in diabetes,” Japanese Journal of Clinical Medicine, vol. 69, supplement 1, pp. 171–175, 2011. View at Google Scholar · View at Scopus
  26. T. Jiang, Z. Huang, Y. Lin, Z. Zhang, D. Fang, and D. D. Zhang, “The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy,” Diabetes, vol. 59, no. 4, pp. 850–860, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Nguyen, P. J. Sherratt, and C. B. Pickett, “Regulatory mechanisms controlling gene expression mediated by the antioxidant response element,” Annual Review of Pharmacology and Toxicology, vol. 43, pp. 233–260, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Dong, Y. Jia, X. Liu et al., “Sodium butyrate activates NRF2 to ameliorate diabetic nephropathy possibly via inhibition of HDAC,” Journal of Endocrinology, vol. 232, no. 1, pp. 71–83, 2017. View at Publisher · View at Google Scholar
  29. B. N. Nakamura, G. Lawson, J. Y. Chan et al., “Knockout of the transcription factor NRF2 disrupts spermatogenesis in an age-dependent manner,” Free Radical Biology and Medicine, vol. 49, no. 9, pp. 1368–1379, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Zheng, S. A. Whitman, W. Wu et al., “Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy,” Diabetes, vol. 60, no. 11, pp. 3055–3066, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Wu, L. Kong, Y. Cheng et al., “Metallothionein plays a prominent role in the prevention of diabetic nephropathy by sulforaphane via up-regulation of Nrf2,” Free Radical Biology & Medicine, vol. 89, pp. 431–442, 2015. View at Publisher · View at Google Scholar
  32. Y. Wang, Z. Zhang, W. Guo et al., “Sulforaphane reduction of testicular apoptotic cell death in diabetic mice is associated with the upregulation of Nrf2 expression and function,” American Journal of Physiology—Endocrinology and Metabolism, vol. 307, no. 1, pp. E14–E23, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Bai, W. Cui, Y. Xin et al., “Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation,” Journal of Molecular and Cellular Cardiology, vol. 57, no. 1, pp. 82–95, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. Q. Liu, G. Wang, G. Zhou et al., “Angiotensin II-induced p53-dependent cardiac apoptotic cell death: its prevention by metallothionein,” Toxicology Letters, vol. 191, no. 2-3, pp. 314–320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Zhou, X. Li, D. W. Hein et al., “Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart,” Journal of the American College of Cardiology, vol. 52, no. 8, pp. 655–666, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Ben Halima, A. Ben Slima, I. Moalla et al., “Protective effects of oat oil on deltamethrin-induced reprotoxicity in male mice,” Food and Function, vol. 5, no. 9, pp. 2070–2077, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. A. T. Farag, A. H. Radwan, M. H. Eweidah, R. H. Elmazoudy, and A. E.-K. El-Sebae, “Evaluation of male-mediated reproductive toxic effects of methamidophos in the mouse,” Andrologia, vol. 44, no. 2, pp. 116–124, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Cai, J. Wang, Y. Li et al., “Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy,” Diabetes, vol. 54, no. 6, pp. 1829–1837, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Wang, W. Feng, W. Xue et al., “Inactivation of GSK-3β by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling,” Diabetes, vol. 58, no. 6, pp. 1391–1402, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Wu, S. Zhou, L. Kong et al., “Metallothionein deletion exacerbates intermittent hypoxia-induced renal injury in mice,” Toxicology Letters, vol. 232, no. 2, pp. 340–348, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Wu, L. Kong, Y. Tan et al., “C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21,” Diabetologia, vol. 59, no. 7, pp. 1558–1568, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Azenabor, A. O. Ekun, and O. Akinloye, “Impact of inflammation on male reproductive tract,” Journal of Reproduction and Infertility, vol. 16, no. 3, pp. 123–129, 2015. View at Google Scholar · View at Scopus
  43. E. J. Calabrese, G. Dhawan, R. Kapoor, I. Iavicoli, and V. Calabrese, “HORMESIS: a fundamental concept with widespread biological and biomedical applications,” Gerontology, vol. 62, no. 5, pp. 530–535, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. E. J. Calabrese, “Hormesis: changing view of the dose-response, a personal account of the history and current status,” Mutation Research - Reviews in Mutation Research, vol. 511, no. 3, pp. 181–189, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. C. A. Houghton, R. G. Fassett, and J. S. Coombes, “Sulforaphane: translational research from laboratory bench to clinic,” Nutrition Reviews, vol. 71, no. 11, pp. 709–726, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. P. E. Pergola, M. Krauth, J. W. Huff et al., “Effect of bardoxolone methyl on kidney function in patients with T2D and stage 3b-4 CKD,” American Journal of Nephrology, vol. 33, no. 5, pp. 469–476, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. E. T. Hall and V. Bhalla, “Is there a sweet spot for nrf2 activation in the treatment of diabetic kidney disease?” Diabetes, vol. 63, no. 9, pp. 2904–2905, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. R. Gold, L. Kappos, D. L. Arnold et al., “Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis,” New England Journal of Medicine, vol. 367, pp. 1098–1107, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. D. H. Ellison, “Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease,” New England Journal of Medicine, vol. 370, no. 18, pp. 1768–1769, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. D. D. Zhang, “Bardoxolone brings Nrf2-based therapies to light,” Antioxidants and Redox Signaling, vol. 19, no. 5, pp. 517–518, 2013. View at Publisher · View at Google Scholar · View at Scopus